XNK Therapeutics logo
Svenska
Svenska
  • About
    About
    Close
    • Overview
    • Leadership Team
    • Board of Directors
      Senior Advisors
  • Technology
    Technology
    Close
    • Autologous NK Cell Therapy Platform
    • GMP Facility
    • Learn about NK cells
  • Project Portfolio
  • Collaborations
  • Newsroom
    Newsroom
    Close
    • Press releases
    • CEO Quarterly Statement
    • Calendar
  • Join Us
    Join Us
    Close
    • Vacant positions
  • Contact
  • About
    • Overview
    • Leadership Team
    • Board of Directors
    • Senior Advisors
  • Technology
    • Autologous NK Cell Therapy Platform
    • GMP Facility
    • Learn about NK cells
  • Project Portfolio
  • Collaborations
  • Newsroom
    • Press releases
    • CEO Quarterly Statement
    • Calendar
  • Join Us
    • Vacant positions
  • Contact

Press releases

2019
  • 2023
  • 2022
  • 2021
  • 2020
  • 2018
  • 2017
  • All years
November 1, 2019

XNK patent for expansion of NK cells validated in 18 European countries

XNK Therapeutics AB (“XNK”) today announced its European patent for the process of expanding NK cells has been validated in 18 countries across the region. The patent covers XNK’s production…

August 1, 2019

XNK Therapeutics patent for expansion of NK cells granted in Japan

XNK Therapeutics AB (“XNK”) today announced that Japan has granted the company a patent for its process of expanding NK cells The patent covers XNK’s production methods for expansion and…

June 1, 2019

XNK patent for expansion of NK cells granted in Europe

XNK Therapeutics AB (“XNK”) today announced it has received a European patent for the process of expanding NK cells. The patent covers XNK’s production methods for large scale expansion and…

  • Newsroom
    • Press releases
    • CEO Quarterly Statement
    • Calendar

Subscribe

Read more about our protection of your personal data.

XNK Therapeutics AB

Hälsovägen 7, Novum
141 57 Huddinge
SWEDEN

Email: info@xnktherapeutics.com

© 2023 XNK Therapeutics

  • Cookies
  • Privacy Policy
  • Integritetspolicy avseende aktieägare